100 related articles for article (PubMed ID: 12005373)
1. Host modulation: conceptualization to clinical trials and integration into clinical practice.
Ryan ME
J Calif Dent Assoc; 2002 Apr; 30(4):285-8, 290-5. PubMed ID: 12005373
[TBL] [Abstract][Full Text] [Related]
2. Clinical applications for host modulatory therapy.
Ryan ME
Compend Contin Educ Dent; 2002 Nov; 23(11A):1071-6, 1079-80, 1082. PubMed ID: 12789987
[TBL] [Abstract][Full Text] [Related]
3. Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis. A review.
Preshaw PM; Hefti AF; Jepsen S; Etienne D; Walker C; Bradshaw MH
J Clin Periodontol; 2004 Sep; 31(9):697-707. PubMed ID: 15312090
[TBL] [Abstract][Full Text] [Related]
4. Host response modulation in the management of periodontal diseases.
Salvi GE; Lang NP
J Clin Periodontol; 2005; 32 Suppl 6():108-29. PubMed ID: 16128833
[TBL] [Abstract][Full Text] [Related]
5. Using host response modifiers in the treatment of periodontal disease. "The clinicians' view". [Interview].
Chichetti S; Bader H; Smith S; Barnett N; Barecki R; Testa D; Giannini J; Bass D; Vines I; DiSalvo P
Pract Proced Aesthet Dent; 2002; 14(9):suppl 12-5. PubMed ID: 12685429
[TBL] [Abstract][Full Text] [Related]
6. Using host response modifiers in the treatment of periodontal disease.
Novak MJ; Donley TG
Pract Proced Aesthet Dent; 2002; 14(9):suppl 3-10; quiz 11. PubMed ID: 12685424
[TBL] [Abstract][Full Text] [Related]
7. Host response modulation in periodontics.
Preshaw PM
Periodontol 2000; 2008; 48():92-110. PubMed ID: 18715360
[No Abstract] [Full Text] [Related]
8. Efficacy of subantimicrobial-dose doxycycline in the treatment of periodontal diseases: a critical evaluation.
Greenstein G
Int J Periodontics Restorative Dent; 2004 Dec; 24(6):528-43. PubMed ID: 15626316
[TBL] [Abstract][Full Text] [Related]
9. Host modulation therapeutics in periodontics: role as an adjunctive periodontal therapy.
Shinwari MS; Tanwir F; Hyder PR; Bin Saeed MH
J Coll Physicians Surg Pak; 2014 Sep; 24(9):676-84. PubMed ID: 25233975
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the host response in the treatment of periodontitis.
Golub LM; Ryan ME; Williams RC
Dent Today; 1998 Oct; 17(10):102-6, 108-9. PubMed ID: 10752438
[TBL] [Abstract][Full Text] [Related]
11. An emerging new standard of care: initial and continued treatment for patients with signs and symptoms of active periodontal disease.
Graham L
Gen Dent; 2003; 51(6):570-7; quiz 578. PubMed ID: 15055657
[TBL] [Abstract][Full Text] [Related]
12. Host-mediated resolution of inflammation in periodontal diseases.
Kantarci A; Hasturk H; Van Dyke TE
Periodontol 2000; 2006; 40():144-63. PubMed ID: 16398691
[No Abstract] [Full Text] [Related]
13. The design and implementation of trials of host modulation agents.
Offenbacher S; Salvi GE; Beck JD; Williams RC
Ann Periodontol; 1997 Mar; 2(1):199-212. PubMed ID: 9151554
[TBL] [Abstract][Full Text] [Related]
14. New directions in host modulation for the management of periodontal disease.
Bhatavadekar NB; Williams RC
J Clin Periodontol; 2009 Feb; 36(2):124-6. PubMed ID: 19207887
[TBL] [Abstract][Full Text] [Related]
15. Systemic medications: clinical significance in periodontics.
Ciancio SG
J Clin Periodontol; 2002 May; 29 Suppl 2():17-21. PubMed ID: 12087965
[TBL] [Abstract][Full Text] [Related]
16. The effects of the initial treatment phase and of adjunctive low-dose doxycycline therapy on clinical parameters and MMP-8, MMP-9, and TIMP-1 levels in the saliva and peripheral blood of patients with chronic periodontitis.
Górska R; Nedzi-Góra M
Arch Immunol Ther Exp (Warsz); 2006; 54(6):419-26. PubMed ID: 17122880
[TBL] [Abstract][Full Text] [Related]
17. Studies on periodontitis and analyses of individuals at risk for periodontal diseases.
Jansson H
Swed Dent J Suppl; 2006; (180):5-49. PubMed ID: 16838563
[TBL] [Abstract][Full Text] [Related]
18. The use of doxycycline in periodontology. Histologic in vivo study on mice affected by diabetes mellitus.
Kol R; Palattella A
Minerva Stomatol; 2006; 55(1-2):77-86. PubMed ID: 16495875
[TBL] [Abstract][Full Text] [Related]
19. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
Onoue S; Misaka S; Kawabata Y; Yamada S
Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive subantimicrobial dose doxycycline: effect on clinical parameters and gingival crevicular fluid transforming growth factor-beta levels in severe, generalized chronic periodontitis.
Gürkan A; Cinarcik S; Hüseyinov A
J Clin Periodontol; 2005 Mar; 32(3):244-53. PubMed ID: 15766366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
